Regarding the stocks with the biggest decline in pharmaceutical stocks, this paper will focus on the stocks with the biggest decline in pharmaceutical stocks, the stocks with no increase in pharmaceutical stocks, the stocks with polarization in pharmaceutical stocks, the stocks with sharp increase in pharmaceutical stocks, and the stocks with low prices and high dividends. I hope it helps you.
Pharmaceutical stocks fell the most.
One of the stocks with the biggest decline in pharmaceutical stocks is Kangmei Bio (300439). By the close of 65438+1October 3 1 in 2023, the share price of Kangmei Bio (300439) was 14.48 yuan, a decrease of 9.95%. In addition, the share prices of BGI (300 176) and Mingde Bio (002932) also fell by 17.27% and 16.69% respectively.
The above information is for reference only, investment is risky, and decision-making needs to be cautious.
Pharmaceutical stocks did not rise.
The following are some pharmaceutical stocks that have not performed well recently:
_ _ Baiyun Mountain (600332): The stock began to decline on August 22, 2022, and has not rebounded so far. The stock price has fallen by 46.53%.
_ _ Wuxi PharmaTech (02350): The stock has been falling since August, 2022 10, and has not rebounded so far. The stock price has fallen by 44.35%.
_ _ Hengrui Pharma (6006 12): The stock has been falling since August 20th, 2022, and has not rebounded yet. The stock price has fallen by 4 1.43%.
_ _ zhifei Bio (300 122): The stock has been falling since August 18, 2022, and has not rebounded so far. The share price has fallen by 39. 16%.
_ _ Mindray Medical (300760): The stock has been falling since August 18, 2022, and has not rebounded so far. The share price has fallen by 38.96%.
The pharmaceutical stocks listed above have not performed well recently, so investors should fully consider the risk factors when making investment decisions.
The pharmaceutical stocks are polarized.
The polarization of pharmaceutical stocks is as follows:
1. recovery class: this class of stocks includes pharmaceutical commercial stocks and Chinese medicine stocks. Pharmaceutical commercial stocks are strong, while Chinese medicine stocks are relatively weak.
2. Innovative drugs: The trend of such stocks is strong, especially the listed companies of innovative drugs, such as Fosun Pharma, Livzon Group, Changchun Gaoxin and Kangtai Bio.
3. Vaccine: The trend of such stocks is also relatively strong, such as zhifei Bio, Wanbangda, Changhong Huayi, He Shan Fu Yao, Tonghua Jinma, Southwest Synthetic, Tiantan Bio, Orchid Bio, Neptune Bio, Ke Hua Bio, Tian Li Gaoxin, Jiaotong University Only, Tibet Pharmaceutical, Yaozhun Co., Ltd., Haichuang Pharmaceutical, Shi Yao Science and Technology, Kanglong Chenghua, etc.
In addition, Xinhua Pharmaceutical, Hualan Bio, Kaisheng New Materials, Kangtai Bio, Wan Tai Bio, anke biotechnology, Yu Jinlong, Zhichunjing Energy, Teyi Pharmaceutical 002727 and Renfu Technology 600790 also performed well. In a research report of the pharmaceutical industry, a number of pharmaceutical stocks were rated as mid-line stocks, including Hualan Bio 002007, Rheinland Bio 002 144, Qianjin Pharmaceutical 600479, Tonghua Jinma 00766, Healthy Yuan 600657, Harbin Pharmaceutical Group 600664, Jiang Zhong Pharmaceutical 600750, Zhendong Pharmaceutical 603488 and Xinlitai.
Investment is risky and decision-making needs to be cautious. It is recommended that you consult a professional investment consultant before carrying out specific operations.
Pharmaceutical stocks rose sharply.
On July 13, pharmaceutical stocks rose sharply, with the increase of Medicis, Kangtai Medicine, Aohua Endoscope, Kangtai Medicine, Aipeng Medical, Medicis, Aohua Endoscope, Aipeng Medical, Mindray Medical, Medicine Stone Technology, Medicis, Kangtai Medical, Aipeng Medical, Aohua Endoscope, Mindray Medical, Medicine Stone Technology and Medicine Stone Technology exceeding/kloc.
There are 20 stocks with an increase of more than 6%. The total turnover of A shares is 65.438+024.048 billion shares, the turnover is 65.438+055.492 billion yuan, and the turnover rate is 26.5438+07%.
Pharmaceutical stocks are stocks with low prices and high dividends.
Pharmaceutical stocks with low prices and high dividends are as follows:
_ _ _ _ _ Hengrui Pharmaceutical. _ _ _ _ Company is the largest anti-tumor drug research and development enterprise in China, with strong research and development strength in the field of cancer, and has formed the whole industrial chain layout from research and development to marketing. In 2022, Hengrui Pharma's dividend plan was 10 to send 2.5 yuan, with a total dividend of 61050,000 yuan.
_ _ _ _ Changchun High-tech. _ _ _ _ Company is one of the leading growth hormone companies in China, and its product indications cover children, adolescents, adults with growth hormone deficiency, chronic diseases, and stress ulcer patients who need to heal related bone growth and granulation tissue formation, such as burns, injuries and fractures. In 2022, the dividend plan of Changchun Hi-Tech is 10 yuan, with a total dividend of 4.629 billion yuan.
_ _ _ _ _ Aier Ophthalmology. _ _ _ _ Company is one of the largest ophthalmic medical institutions in China and the largest ophthalmic medical beauty institution in the world. Its ophthalmic medical equipment and medical technology are at the international leading level, and it is a leading enterprise in the field of refractive ophthalmic surgery in the world. In 2022, Aier Ophthalmology Dividend Scheme will send 10 6 yuan, with a total dividend of 4.563 billion yuan.
_ _ _ _ _ is in good health in America. _ _ _ _ Company is one of the largest chain medical diagnosis service providers in China. Through comprehensive coverage of public hospitals, community centers, high-end physical examination clubs, trade fairs and other diversified service networks, we will provide comprehensive medical diagnosis services for people of all ages. In 2022, the health dividend plan was 10 to send 1.6 yuan, with a total dividend of 3.469 billion yuan.
_ _ _ _ _ Lepu Medical. _ _ _ _ Company is one of the earliest enterprises engaged in the research, development and production of cardiovascular interventional diagnostic instruments in China. Its products cover cardiovascular diagnostic instruments and equipment, implantable medical devices and in vitro diagnostic reagents and instruments. In 2022, Lepu Medical's dividend plan was 10 to 2 yuan, with a total dividend of 3.439 billion yuan.
These are just some pharmaceutical stocks with low prices and high dividends. Investors need to combine more data and information to evaluate investment risks when choosing.
The introduction of the pharmaceutical stocks with the biggest decline ends here.